IP Library › Granted Patent US 12,357,250
Granted Patent B2
US 12,357,250 · App. 16/837,187 · Granted Jul 15, 2025

System and method of using temporal measurements of localized radiation to estimate the magnitude, location, and volume of radioactive material in the body

Inventors: Steven Perrin (Durham, NC); Joshua G. Knowland (Cary, NC)
Assignee: Lucerno Dynamics, LLC
A61B6/4057A61B6/4258A61B6/4266G01T1/1641
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,357,250
App. No.
16/837,187
Granted
Jul 15, 2025
Kind
B2
Abstract

A system and method for the measurement of radiation emitted from the body, for example, is presented. In one example, radiation sensors (e.g., gamma radiation sensors) may be used to measure activity proximate an injection site as a function of time. With that data, a function describing an amount of radioactive material in tissue proximate the injection site as a function of time may be estimated where an amount of radioactive material in the tissue at a time t is known. When an array of sensors is employed, the amount of radioactive material in the tissue proximate the injection site may be determined directly by the system. With an estimated function of radioactive material proximate the injection site as a function of time known, an estimated arterial input function may be determined, allowing for calculation of a correction factor that may be applied by a clinician during nuclear medical imaging.

Claims (34)

1. A method for the ex vivo real-time detection over a period of time of radiation emitted by a subject from the administration of a radioactive analyte that decays in vivo, the method comprising:

(i) positioning an array of ex vivo radiation measurement sensors proximate to a point of administration on the subject of the radioactive analyte, wherein the array has a known geometry and relative distances between the sensors are known;

(ii) detecting radiation over a desired period of time and producing signal data associated with the desired period of time, wherein the measurement sensors each have at least one sensor output for such signal data, and outputting the signal data;

(iii) processing the signal data using a computer processor in operative communication with a non-transient memory and the measurement sensor outputs by performing the steps of:

(a) receiving the signal data associated with the desired period of time;

(b) using a measured value of radioactive material proximate the point of administration at a time t, estimating a function of radioactive material proximate the point of administration from a time of administration to the time t based only on the signal data associated with the desired period of time;

(c) determining, based on the estimated function of radioactive material proximate the point of administration, a radioactivity, location, and volume of radioactive material disposed in body tissue proximate the point of injection from the time of administration to the time t.

2. The method of claim 1 , further comprising the step of amplifying the signal data using a signal amplifier in operable communication with the radiation sensors.

3. The method of claim 1 , further comprising the step of estimating a dose of radiation to an area of affected tissue.

4. A system for the ex vivo real-time detection over a period of time of radiation emitted by a subject from the administration of a radioactive analyte that decays in vivo, the system comprising:

at least one ex vivo radiation measurement sensor to detect radiation over a desired period of time and to produce signal data associated with the desired period of time, the ex vivo measurement sensor adapted to sensing radiation proximate to a point of administration on the subject of the radioactive analyte;

a signal amplifier in operable communication with the radiation measurement sensor, the signal amplifier adapted to amplify the signal data, the radiation measurement sensor having at least one sensor output for such amplified signal data;

at least one computer processor and a non-transient memory, the computer processor in operable communication with the non-transient memory and the measurement sensor output;

wherein the non-transient memory includes computer program code executable by the at least one computer processor, the computer program code configured for performing the steps of receiving the amplified signal data with the desired period of time, accessing a measured amount of radioactive material proximate the point of administration at a time t, and using the amplified signal data alone, estimating a function of radioactive material proximate the point of injection as a function of time from a time of injection to time t;

wherein the measured value of radioactive material proximate the point of administration at time t is measured using an array of two or more ex vivo radiation measurement sensors, wherein the array has a known geometry and relative distances between the sensors are known such that a distance from the array to a radiometric center of the radioactive material being measured can be determined, and further wherein a radioactivity, location, and volume of the radioactive material being measured can be determined.

5. The system of claim 4 , further comprising the step of convolving the estimated function with a known impulse response from a typical bolus injection using the computer processor, and calculating a correction factor to be applied to one or more measurements made using a nuclear imaging device.

6. A method for the ex vivo real-time determination over a period of time of the radioactivity, location, and volume of a radioactive source in the body by measuring radiation that decays in vivo emitted by a subject, the method comprising:

(i) applying one or more ex vivo radiation measurement sensors proximate an area of interest on a patient;

(ii) detecting radiation over a desired period of time and producing signal data associated with the desired period of time;

(iii) amplifying the signal data using a signal amplifier in operable communication with the radiation measurement sensor, wherein the radiation measurement sensor has at least one sensor output for such amplified signal data, and outputting the amplified signal data;

(iv) processing the amplified signal data using a computer processor in operative communication with a non-transient memory and the measurement sensor output by performing the steps of:

(a) receiving the amplified signal data associated with the desired period of time;

(b) comparing the amplified signal data to a set of expected signal data for radioactive sources of various radioactivities, locations, and volumes;

(c) determining a radioactivity, location, and volume of the radioactive source in the body over the desired period of time by fitting the amplified signal data to the most likely set of expected signal data.

7. The method of claim 6 , wherein a Maximum Likelihood Expectation Maximization method is used to fit the most likely radioactivity, location, and volume of the radioactive source in the body.

8. The method of claim 6 , further comprising the step of determining a dose of radioactivity to an area of tissue proximate the location of the radioactive source.

9. The method of claim 6 , further comprising the step of using the determined radioactivity, location, and volume of radioactive source in the body to make one or more of a clinical decision or diagnosis.

10. The method of claim 6 , wherein an array comprising two or more of the ex vivo radiation measurement sensors is utilized.

11. The method of claim 10 , wherein the array of two or more sensors are disposed in a substantially symmetric geometry about the radioactive source in the body.

12. The method of claim 10 , wherein the two or more radiation measurement sensors are disposed proximate one or more desired measurement locations, and further wherein each desired measurement location comprises at least a first sensor disposed relatively closer to the radioactive source than a second sensor.

13. The method of claim 6 , wherein radioactivity, location, and volume are determined for two or more radiation sources in the body.

14. The method of claim 13 , further comprising the step of comparing the determined radioactivity, location, or volume of the two or more radioactive sources, and making a clinical decision or diagnosis based on the comparison.

15. The method of claim 14 , wherein the clinical decision or diagnosis is also based on one or more prior determinations or comparisons of the subject patient.

16. The method of claim 14 , wherein the clinical decision or diagnosis is further based on a comparison to a table comprising data from a population of other patients.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Sep 16, 2026
From: SMALLING, ANNE M.; RJS DE LLC; KIRT LATTANZE & ASSOCIATES, INC.; 1705,LLC; GEORGIA COMMERCIAL STORES, INC.; WESTERN SKIES PARTNERS; GUIDO NEELS; HOOK INVESTMENTS, LLC; BASARIA, AMIN S.; SLANE, SUSAN; BOSTIAN, JAMES M.; BOSTIAN, KRISTEN C.; WILLIAMS, RICHARD B., JT; WILLIAMS, MEREDITH U.; WILLIAMS, ROB, JT; WILLIAMS, WHTINEY; SMALLING FAMILY PARTNERSHIP
To: RADNOSTIX, INC., A TEXAS CORPORATION C/O SHAHE BAGERDJIAN
Reel/Frame 076039/0412 →
RELEASE OF SECURITY INTEREST Recorded Sep 11, 2026
From: RJS DE LLC; KIRT LATTANZE & ASSOCIATES, INC.; 1705, LLC; GEORGIA COMMERCIAL STORES, INC.; WESTERN SKIES PARTNERS; NEELS, GUIDO; HOOK INVESTMENTS, LLC; BASARIA, AMIN S.; SLANE, SUSAN; BOSTIAN, JAMES M. AND KRISTEN C.; WILLIAMS, JT, RICHARD B. AND MEREDITH U.; WILLIAMS, JT, ROB AND WHITNEY; SMALLING FAMILY PARTNERSHIP
To: LUCERNO DYNAMICS, LLC
Reel/Frame 075987/0727 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2026
From: LUCERNO DYNAMICS, LLC
To: RADNOSTIX, INC.
Reel/Frame 075944/0446 →
SECURITY INTEREST Recorded Dec 22, 2025
From: LUCERNO DYNAMICS, LLC
To: RJS DE LLC; KIRT LATTANZE & ASSOCIATES, INC.; 1705, LLC; GEORGIA COMMERCIAL STORES, INC.; WESTERN SKIES PARTNERS; GUIDO NEELS; HOOK INVESTMENTS, LLC; BASARIA, AMIN S.; SLANE, SUSAN; BOSTIAN, JAMES M. AND KRISTEN C.; WILLIAMS, JT, RICHARD B. AND MEREDITH U.; WILLIAMS, JT, ROB AND WHITNEY; SMALLING FAMILY PARTNERSHIP
Reel/Frame 074021/0640 →
Continuity (2)
Provisional Application 62828033 · Apr 2, 2019
Related Publication 20200315558A1 · Oct 8, 2020
References Cited (70)
US 4095107A · Genna · 1978 [cited by examiner]
US 4629894A · Lelong · 1986 [cited by applicant]
US 4682604A · Fymat et al. · 1987 [cited by applicant]
US 4692890A · Arseneau · 1987 [cited by applicant]
US 4881171A · Jattteau et al. · 1989 [cited by applicant]
US 5007427A · Suzuki et al. · 1991 [cited by applicant]
US 5309357A · Stark et al. · 1994 [cited by applicant]
US 5428223A · Jatteau et al. · 1995 [cited by applicant]
US 5583343A · Dilmania et al. · 1996 [cited by applicant]
US 5647363A · Rabito et al. · 1997 [cited by applicant]
US 5821538A · De Antoni et al. · 1998 [cited by applicant]
US 6448544B1 · Stanton et al. · 2002 [cited by applicant]
US 7711409B2 · Keppel et al. · 2010 [cited by applicant]
US 7972259B2 · Rozenfeld · 2011 [cited by examiner]
US 8565860B2 · Kimchy et al. · 2013 [cited by applicant]
US 8680476B2 · Webster et al. · 2014 [cited by applicant]
US 9939533B2 · Knowland · 2018 [cited by examiner]
US 10471162B2 · Desogere · 2019 [cited by examiner]
US 20010002250A1 · Burbank · 2001 [cited by examiner]
US 20020137991A1 · Scarantino et al. · 2002 [cited by applicant]
US 20030012731A1 · Suddarth et al. · 2003 [cited by applicant]
US 20030108229A1 · Tanaka · 2003 [cited by examiner]
US 20030189657A1 · Hammadou · 2003 [cited by applicant]
US 20050143927A1 · Cammia et al. · 2005 [cited by applicant]
US 20050287065A1 · Suddarth et al. · 2005 [cited by applicant]
US 20060076523A1 · Higashiisogawa et al. · 2006 [cited by applicant]
US 20080161632A1 · Rozenfeld · 2008 [cited by examiner]
US 20090150315A1 · Wirtz et al. · 2009 [cited by applicant]
US 20090226915A1 · Guyon · 2009 [cited by applicant]
US 20090250602A1 · Black et al. · 2009 [cited by applicant]
US 20090266993A1 · Baerwolff et al. · 2009 [cited by applicant]
US 20100010343A1 · Daghighian et al. · 2010 [cited by applicant]
US 20100198061A9 · Daghighian et al. · 2010 [cited by applicant]
US 20100268078A1 · Suddarth et al. · 2010 [cited by applicant]
US 20110196234A1 · Buono et al. · 2011 [cited by applicant]
US 20110301863A1 · Auribault et al. · 2011 [cited by applicant]
US 20140018675A1 · Keppel et al. · 2014 [cited by applicant]
US 20150276937A1 · Knowland · 2015 [cited by examiner]
US 20160303397A1 · Hirschman et al. · 2016 [cited by applicant]
US 20170360967A1 · Desogere · 2017 [cited by examiner]
US 20180047555A1 · Pringle et al. · 2018 [cited by applicant]
US 20180172844A1 · Knowland et al. · 2018 [cited by applicant]
US 20200031558A1 · Iwamoto · 2020 [cited by applicant]
US 20210015434A1 · Perrin et al. · 2021 [cited by applicant]
US 20210128082A1 · Cohen et al. · 2021 [cited by applicant]
JP 2002196080A · 2002 [cited by applicant]
JP 2009133803 · 2009 [cited by applicant]
JP 2011163966A · 2011 [cited by applicant]
JP 2016197092 · 2016 [cited by applicant]
WO 2007140352A2 · 2007 [cited by applicant]
WO 2009158143A1 · 2009 [cited by applicant]
WO 2010039298A2 · 2010 [cited by applicant]
WO 2020206092 · 2020 [cited by applicant]
International Search report dated Feb. 19, 2014. [cited by applicant]
Son, C. et al, An Implantable Wireless Microdosimeter for Radiation Oncology, School of Electrical and Computer Engineering, Mems 2008, Jan. 13-17, 2008, pp. 256-259. [cited by applicant]
Basak, Abhishek, Low-Power Implantable Ultrasound Imager for Online Monitoring of Tumor Growth, 33rd Annual Intl Conference of the IEEE EMBS, Boston, MA., Aug. 30-Sep. 3, 2011, pp. 2858-2861. [cited by applicant]
Extended European Search Report dated Nov. 11, 2016. [cited by applicant]
S.D. Wollenweber et al, “A Simple On-Line Arterial Time-Activity Curve Detector for [0-15] Water PET Studies”, IEEE Transactions on Nuclear Science, vol. 44, No. 3, pp. 1417-1419, Jun. 1997. [cited by applicant]
Weber, A. Wolfgang, Use of PET for Monitoring Cancer Therapy and for Predicting Outcome, The Journal of Nuclear Medicine, vol. 46, No. 6, Jun. 2005 pp. 983-995. [cited by applicant]
Delbeke, Dominique et al., Procedure Guideline for Tumor Imaging with 18F-FDG PET/CT 1.0, The Journal of Nuclear Medicine, vol. 47, No. 5, May 2006 pp. 885-895. [cited by applicant]
Dunnwald, Lisa et al., PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake, Clinical Cancer Research,… [cited by applicant]
Velasquez, Linda M. et al., Repeatability of 18F-FDG PET in a Multicenter Phase I Study of Patients with Advanced Gastrointestinal malignancies, The Journal of Nuclear Medicine, vol. 50, No. 10, Oct. 2009, pp. 1646-1654. [cited by applicant]
Osman, Medhat M. et al., FDG dose extravasations in PET/CT: frequency and impact on SUV measurements, Front. Oncol., Nov. 16, 2011, http://journal.frontiersin.org/article/10.3389/fonc.2011.00041/full. [cited by applicant]
Office Action dated Aug. 15, 2014. [cited by applicant]
European Patent Office, Search Report for International Patent Application No. 20784501.7, Nov. 7, 2022. [cited by applicant]
United States Patent and Trademark Office (USPTO), Non-Final Office Action for U.S. Appl. No. 17/062,133, filed May 4, 2023. [cited by applicant]
Japan Patent Office, Office Action for International Patent Application No. JP 2021-560415, Jan. 22, 2024. [cited by applicant]
Japanese Patent Office, Japanese Examination Report for International Patent Application No. JP2021-560415, Jun. 24, 2024. [cited by applicant]
United States Patent and Trademark Office, Office Action for U.S. Appl. No. 17/062,133, filed Oct. 24, 2024. [cited by applicant]
Australia Patent and Trademark Office, Australian Examination Report for International Patent Application No. AU2020256211, Oct. 9, 2024. [cited by applicant]